about
Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits.Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the antileishmanial efficacy of miltefosine.Halo-substituted thiosemicarbazones and their copper(II), nickel(II) complexes: detailed spectroscopic characterization and study of antitumour activity against HepG2 human hepatoblastoma cells.Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation.Spectroscopic characterization, antioxidant and antitumour studies of novel bromo substituted thiosemicarbazone and its copper(II), nickel(II) and palladium(II) complexesSynthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model
P50
Q33521597-C47B863F-5F32-417B-B161-51A74C119272Q34022297-D65B5CD0-133B-4F96-BEBE-D6428A5150E4Q38736536-F9E190E8-5478-47FA-A76D-B67ED982BC5EQ43790300-A6AC6AAB-7F0C-4C08-8101-0C52C4A20987Q55314046-769F16F7-E83C-4B6E-8C67-3E4C5DC77416Q57161237-CF1ED746-2D13-48CB-B44D-6BF5268AAC99Q90477834-15E9F01F-A9FE-4801-B037-1638BD0929F5
P50
description
researcher ORCID ID = 0000-0002-7328-9322
@en
wetenschapper
@nl
name
Suresh K Kalangi
@ast
Suresh K Kalangi
@en
Suresh K Kalangi
@es
Suresh K Kalangi
@nl
type
label
Suresh K Kalangi
@ast
Suresh K Kalangi
@en
Suresh K Kalangi
@es
Suresh K Kalangi
@nl
prefLabel
Suresh K Kalangi
@ast
Suresh K Kalangi
@en
Suresh K Kalangi
@es
Suresh K Kalangi
@nl
P106
P1153
36519058200
P31
P496
0000-0002-7328-9322